These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Torcetrapib and atorvastatin. Green AM N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16211710 [No Abstract] [Full Text] [Related]
4. Torcetrapib and atorvastatin--should marketing drive the research agenda? Avorn J N Engl J Med; 2005 Jun; 352(25):2573-6. PubMed ID: 15972861 [No Abstract] [Full Text] [Related]
5. Noninferiority of pitavastatin in intravascular ultrasound findings. Kaneda H; Ma J; Morita T J Am Coll Cardiol; 2010 Jan; 55(3):262-3; author reply 263. PubMed ID: 20117416 [No Abstract] [Full Text] [Related]
6. Statin treatment in patients with elevated liver enzymes: pitch to proceed. Berkelhammer C; Lerma EV J Clin Lipidol; 2012; 6(4):310-1. PubMed ID: 22836066 [No Abstract] [Full Text] [Related]
7. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study]. Takeuchi T; Ota H; Hasebe N Nihon Rinsho; 2011 Nov; 69 Suppl 9():336-40. PubMed ID: 22724225 [No Abstract] [Full Text] [Related]
8. Generic atorvastatin and health care costs. Jackevicius CA; Chou MM; Ross JS; Shah ND; Krumholz HM N Engl J Med; 2012 Jan; 366(3):201-4. PubMed ID: 22149736 [No Abstract] [Full Text] [Related]
9. Study highlights need for considered clinical approach to statin switching. Lloyd K Int J Clin Pract; 2007 May; 61(5):880; author reply 880-1. PubMed ID: 17493097 [No Abstract] [Full Text] [Related]
10. Qualitative plaque stabilization but not quantitative plaque regression. Nishigaki K Circ J; 2012; 76(4):809-11. PubMed ID: 22451448 [No Abstract] [Full Text] [Related]
13. Who benefits from statins? Patient or focal plaque? Fujii K; Masuyama T Circ J; 2012; 76(12):2744-5. PubMed ID: 23117744 [No Abstract] [Full Text] [Related]
14. New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells. Moriguchi H; Chung RT; Sato C Hepatology; 2010 Jan; 51(1):344-5; author reply 345. PubMed ID: 19957377 [No Abstract] [Full Text] [Related]
15. Relationship between atorvastatin dose and the harm caused by torcetrapib. Barter PJ; Rye KA; Beltangady MS; Ports WC; Duggan WT; Boekholdt SM; DeMicco DA; Kastelein JJ; Shear CL J Lipid Res; 2012 Nov; 53(11):2436-42. PubMed ID: 22941786 [TBL] [Abstract][Full Text] [Related]
16. Atorvastatin in nonischemic left ventricular systolic dysfunction. Bahl A; Chongtham DS J Am Coll Cardiol; 2006 Sep; 48(6):1283; author reply 1284. PubMed ID: 16979019 [No Abstract] [Full Text] [Related]
18. Cholesterol drug may help treat Alzheimer's. Heart Advis; 2005 Jul; 8(7):2. PubMed ID: 16180263 [No Abstract] [Full Text] [Related]
19. Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage). Han KH; Rha SW; Kang HJ; Bae JW; Choi BJ; Choi SY; Gwon HC; Bae JH; Hong BK; Choi DH; Han KR J Clin Lipidol; 2012; 6(4):340-51. PubMed ID: 22836071 [TBL] [Abstract][Full Text] [Related]